With the joint MASH study between CYDY and MDGL finishing this week I imagine partnership talks will start in the coming weeks if the results are positive and show a synergistic effect. (If they haven’t already been taking place before hand.) Certainly both companies want to see who has the greater advantage and by how much and they might not release the results of the studies until after they come to an agreement.

That’s what I would do if I was either company. If you are MDGL, you don’t want big Pharma knowing those results until you have in a deal with CYDY. if you are, CYDY, you need money and relevance so a partnership is crucial.

So if the data is what I think it is going to be, then I see them inking a deal and then announcing the results at the same time they announce the deal has been signed. Something like MDGL and CYDY have entered into a partnership for MASH. The deal entails… And this is based on the study results, that showed…